Emerging Drug And Gene Delivery Devices Market Trends: The Role Of AI Technology In Advancing Treatment Solutions Shaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Drug And Gene Delivery Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a substantial growth in the market size of drug and gene delivery devices. The market value, which stands at $0.61 billion in 2024, is projected to rise to $0.67 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.0%. This growth during the historic period is a result of factors such as the advancement of healthcare infrastructure, the broadening scope of personalized gene therapy programs, a heightened focus on preventive healthcare, the presence of rare and orphan diseases, and a rise in public awareness regarding health and available treatment options.

How Will the Drug And Gene Delivery Devices Market Size Evolve and Grow by 2029?
The market for drug and gene delivery devices is expected to experience considerable growth in the upcoming years, expanding to $0.93 billion by 2029 at a CAGR of 8.7%. This projected growth within the forecast period can be linked to the rise in chronic diseases, the burgeoning demand for individualized medicine, the growing popularity and understanding of gene therapy, the preference for non-invasive and minimally invasive procedures, and an increasing shift towards direct-to-patient delivery models. The forecast period also highlights trends including advancements in biotechnology and genetic engineering, technological innovations in drug delivery systems, heightened investment in research and development, the creation of new delivery platforms, and advances in diagnostic technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report

What Drivers Are Propelling the Growth of Drug And Gene Delivery Devices Market Forward?
The growing acceptance of gene therapy is anticipated to stimulate the expansion of the drug and gene delivery devices market in the future. Gene therapy is a medical procedure that requires the addition, subtraction, or modification of genetic materials in a person's cells to cure or prevent diseases. The demand for gene therapy has grown due to the promising possibility of resolving genetic disorders and chronic diseases at their origins, providing innovative treatment options where traditional therapies are inadequate. Drug and gene delivery devices play a critical role in gene therapy, ensuring accurate targeting and regulated release of therapeutic genes, thereby improving the effectiveness of treatment. For example, in November 2023, the National Centre for Biotechnology Information, a resource for the research community in the U.S., predicted that the count of new patients treated with gene therapies will increase from 16,244 in 2020 to 94,696 in 2025. Hence, the escalating acceptance of gene therapy is fueling the expansion of the drug and gene delivery devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp

Which Emerging Trends Are Transforming the Drug And Gene Delivery Devices Market in 2025?
Major organizations in the drug and gene delivery devices market are concentrating on producing cutting-edge products, like artificial intelligence (AI) technologies, to establish a unique standing in the market. AI technology, when applied to drug delivery, refers to the use of AI methodologies and algorithms to heighten the proficiency, accuracy, and effectiveness of drug delivery systems. To illustrate, In December 2023, Envoya Inc., an American firm specializing in polymer-based nanoparticles for targeted delivery, introduced a novel gene therapy drug delivery platform. This platform fuses biopolymer-nanoparticles and artificial intelligence (AI) to tackle crucial limitations present in the prevailing gene therapy technologies, including viral vectors and lipid nanoparticles. The platform's objective is to surmount the constraints of former gene therapy delivery technologies, which have been hampered by safety worries, inadequate payload capacities, and restricted tissue targeting.

What Are the Key Segments in the Drug And Gene Delivery Devices Market?
The drug and gene delivery devicesmarket covered in this report is segmented -

1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical

Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp

Who Are the Key Players Shaping the Drug And Gene Delivery Devices Market's Competitive Landscape?
Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics

What Geographic Markets Are Powering Growth in the Drug And Gene Delivery Devices Market?
North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.